NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹325 Cr | ₹309 Cr | ₹303 Cr | ₹273 Cr | ₹22 Cr |
What is the latest Net Current Assets ratio of NATH BIOGENES (INDIA) ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹325 Cr |
Mar2024 | ₹309 Cr |
Mar2023 | ₹303 Cr |
Mar2022 | ₹273 Cr |
Mar2013 | ₹22 Cr |
How is Net Current Assets of NATH BIOGENES (INDIA) Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹325 Cr | 5.01 | |
Mar2024 | ₹309 Cr | 1.92 | |
Mar2023 | ₹303 Cr | 10.94 | |
Mar2022 | ₹273 Cr | 1,164.10 | |
Mar2013 | ₹22 Cr | - |
Compare Net Current Assets of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹332.5 Cr | -1.7% | -5.9% | -22.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,348.9 Cr | -5.2% | -9.3% | -28.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,891.6 Cr | 5.3% | 2% | 4.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,092.6 Cr | 4.3% | -3.8% | -33.6% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,514.7 Cr | 8.3% | 6.2% | -27.6% | Stock Analytics | |
INDO US BIOTECH | ₹297.8 Cr | -2% | -10.7% | -43.2% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -1.7% |
-5.9% |
-22.8% |
SENSEX | -1.1% |
-1.7% |
-0.3% |
You may also like the below Video Courses